journal article·2025-06

Atom-efficient and self-delivered prodrug based on methylene blue and doxorubicin for tumor combination therapy

Yuchen Song, Qiang Wang, Qiankun Shi, Tongyin Xiong, Biru Wu, Jucai Gao, Fang Hu

Dyes and Pigments· Volume 237
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (44)

Show source-provided references
1. Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy10.1186/s12951-023-02064-1 ↗
2. Small‐molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery10.1002/smll.202101460 ↗
3. ROS‐Responsive camptothecin prodrug nanoparticles for on‐demand drug release and combination of chemotherapy and photodynamic therapy10.1002/adfm.202005918 ↗
4. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery10.1016/j.colsurfb.2014.09.029 ↗
5. Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery10.1016/j.actbio.2020.05.026 ↗
6. Rational design of cancer nanomedicine: nanoproperty integration and synchronization10.1002/adma.201606628 ↗
7. Prodrugs: design and clinical applications10.1038/nrd2468 ↗
8. Near-infrared boron–dipyrrin (BODIPY) nanomaterials: molecular design and anti-tumor therapeutics10.1016/j.ccr.2024.215718 ↗
9. Silk fibroin-based nanoparticles for drug delivery10.3390/ijms16034880 ↗
10. Application of polydopamine in tumor targeted drug delivery system and its drug release behavior10.1016/j.jconrel.2018.10.009 ↗
11. A dual-FRET-based versatile prodrug for real-time drug release monitoring and in situ therapeutic efficacy evaluation10.1002/adfm.201503262 ↗
12. A pH‐responsive nanoparticle delivery system containing dihydralazine and doxorubicin‐based prodrug for enhancing antitumor efficacy
13. The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy10.1039/D2CS00673A ↗
14. Emerging small molecule-engineered hybrid nanomedicines for cancer therapy10.1016/j.cej.2022.135160 ↗
15. Enhancing the release efficiency of a molecular chemotherapeutic prodrug by photodynamic therapy10.1002/anie.202206169 ↗
16. Chemiexcitation‐triggered prodrug activation for targeted carbon monoxide delivery10.1002/anie.202200974 ↗
17. H2O2-responsive biodegradable nanomedicine for cancer-selective dual-modal imaging guided precise photodynamic therapy10.1016/j.biomaterials.2019.03.042 ↗
18. Smart activatable and traceable dual-prodrug for image-guided combination photodynamic and chemo-therapy10.1016/j.biomaterials.2017.08.018 ↗
19. Theranostic applications of biomolecule‐responsive aggregation‐induced emission luminogens
20. Specific activation of photosensitizer with extrinsic enzyme for precisive photodynamic therapy10.1021/jacs.2c04017 ↗
21. Urea-bond scission induced by therapeutic ultrasound for biofunctional molecule release10.1021/jacs.2c03669 ↗
22. Switching on prodrugs using radiotherapy10.1038/s41557-021-00711-4 ↗
23. Systematic procedures for formulation design of drug-loaded solid lipid microparticles: selection of carrier material and stabilizer10.1021/ie7017806 ↗
24. Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging10.1038/nmat2608 ↗
25. Facile fabrication of tumor redox-sensitive nanoassemblies of small-molecule oleate prodrug as potent chemotherapeutic nanomedicine10.1002/smll.201601597 ↗
26. Tailoring carrier-free nanocombo of small-molecule prodrug for combinational cancer therapy10.1016/j.jconrel.2022.10.022 ↗
27. Carrier-free nanomedicines for cancer treatment10.1016/j.pmatsci.2021.100919 ↗
28. Rational design of amphiphilic BODIPY-based photosensitizers for multimodal imaging-guided phototherapy10.1039/D3QM00239J ↗
29. Recent progress in carrier‐free nanomedicine for tumor phototherapy10.1002/adhm.202202307 ↗
30. The smart drug delivery system and its clinical potential10.7150/thno.14858 ↗
31. Supramolecular coordination complexes for synergistic cancer therapy10.1021/acs.accounts.4c00031 ↗
32. Phenylthiol-BODIPY-based supramolecular metallacycles for synergistic tumor chemo-photodynamic therapy10.1073/pnas.2203994119 ↗
33. Methylene blue-based near-infrared activatable probes for bioimaging10.1016/j.dyepig.2023.111083 ↗
34. Structural and functional NIR-II fluorescence bioimaging in urinary system via clinically approved dye methylene blue10.1016/j.eng.2021.07.032 ↗
35. Methylene blue-based nano and microparticles: fabrication and applications in photodynamic therapy10.3390/polym13223955 ↗
36. Doxorubicin prodrug-based nanomedicines for the treatment of cancer10.1016/j.ejmech.2023.115612 ↗
37. Supramolecular loading of DNA hydrogels with dye–drug conjugates for real‐time photoacoustic monitoring of chemotherapy10.1002/advs.202204330 ↗
38. Methylene-blue-encapsulated liposomes as photodynamic therapy nano agents for breast cancer cells10.3390/nano9010014 ↗
39. Methylene blue in photodynamic therapy: from basic mechanisms to clinical applications
40. Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer10.1016/j.biomaterials.2008.10.060 ↗
41. An activatable NIR probe for the detection and elimination of senescent cells10.1021/acs.analchem.2c00239 ↗
42. Deformylation reaction-based probe for in vivo imaging of HOCl10.1039/C7SC03784H ↗
43. Methylene blue as a far-red light-mediated photocleavable multifunctional ligand10.1039/C9CC08916K ↗
44. A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice10.1186/s12885-017-3677-7 ↗